Katelyn Vilasi, OD
Optometrist · Rochester, NYNPI 1821518911
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,000 of the $6,256 with a category attached, or 63.9%. Bausch & Lomb Americas Inc. accounts for 74.0% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $4,612, more than ten times the $107 reported in 2019. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $125.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$5K
- Sight Sciences, Inc.$407
- Alcon$323
- Sun Pharmaceutical Industries Inc.$317
- LKC Technologies, Inc.$216
- Amgen$125
- plus $235 from 3 others
What the payments were for
- Consulting fees$4,00064%
- Food & beverage$2,25636%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 19 | $4,632 |
| Sight Sciences, Inc. | 4 | $407 |
| Alcon | 11 | $323 |
| Sun Pharmaceutical Industries Inc. | 3 | $317 |
| LKC Technologies, Inc. | 2 | $216 |
| Amgen | 1 | $125 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $107 |
| Coopervision Inc. | 5 | $88 |
| Johnson & Johnson Vision Care, Inc. | 2 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$328
- CEQUA$220
- TEPEZZA$125
- Precision7$125
- OMNI(R) SURGICAL SYSTEM (US)$112
- TearCare SmartLid$112
- TEARCARE(TM) (2.2) SYSTEM KIT$112
- TEARCARE SYSTEM$112
How this compares
$6,256 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $158 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Rochester
- Vadim GuyRochester$31K
- Lisa ChuteRochester$9K
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.